Emmerich Ilka Ute
Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztl Prax Ausg G Grosstiere Nutztiere. 2022 Jun;50(3):195-199. doi: 10.1055/a-1849-1770. Epub 2022 Jul 5.
In 2021, one novel pharmaceutical agent for horses or food-producing animals was released on the German market, making the anti-haemorrhagic etamsylate (Hemosilate) available for horses, cattle, pigs, sheep, goats, dogs and cats, for the first time. The authorization of one established veterinary active ingredient was extended to an additional species: The endectocide eprinomectin (Eprecis) from the group of macrocyclic lactones was also approved for sheeps and goats. Additionally, two veterinary formulations with a new active substance content (bromhexine, tiamulin) and one active ingredient in a novel pharmaceutical formulation (indigo carmine stained intramammary suspension with heavy bismuth subnitrate) appeared on the market. Furthermore, one active ingredient (oxytetracycline) is again available for horses on the market for horses and food-producing animals.
2021年，一种用于马匹或食用动物的新型药剂在德国市场上市，首次使抗出血的酚磺乙胺（止血敏）可用于马、牛、猪、羊、山羊、狗和猫。一种已有的兽用活性成分的授权范围扩大到了另外一个物种：大环内酯类的体内驱虫药伊维菌素（爱普利）也被批准用于绵羊和山羊。此外，两种含有新活性成分（溴己新、泰妙菌素）的兽用制剂以及一种含有新型药物制剂（重质次硝酸铋靛胭脂染色乳房内悬浮液）的活性成分投放市场。此外，一种活性成分（土霉素）再次在马匹和食用动物市场上可供马匹使用。
